dsip peptide when to take (Delta Sleep-Inducing Peptide) Therapy DSIP, BPC-157, CJC (Sleep Blend)
Description
REGISTRATION: URL: Unique identifier: NCT05567796
The high sensitivity (100% for the known carcinogenic and mutagenic NAs tested here) of HepG2 cells supplemented with hamster S9-mix, as compared to PHH and PRH, in principle might make this system a valuable tool for hazard identification and potential follow up of negative/borderline EAT test results to provide further reassurance for the EAT result
It serves as a research tool for exploring peptide-driven mechanisms in controlled experimental models
No peptide has been proven to cause cancer in humans
